Jefferies Initiates Coverage On Electra Therapeutics with Buy Rating, Announces Price Target of $32
Benzinga Newsdesk 2 weeks ago
Analyst RatingsNewsInitiationPrice Target
Jefferies analyst Akash Tewari initiates coverage on Electra Therapeutics (NASDAQ:ETRA) with a Buy rating and announces Price Target of $32.
Jefferies analyst Akash Tewari initiates coverage on Electra Therapeutics (NASDAQ:ETRA) with a Buy rating and announces Price Target of $32.